Profound Medical (PROF) Shareholder's Equity (2018 - 2026)

Profound Medical (PROF) Shareholder's Equity (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 52.06 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 22.98 Bn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 49.20 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 26.10 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 10.33 Bn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 10.67 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 13.34 Bn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 2.96 Bn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 7.20 Bn
10 Profound Medical 240.29 Mn 190.00 Mn 3.83 Mn 59.42 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 59.42 Mn
Dec 31, 2025 66.43 Mn
Sep 30, 2025 32.14 Mn
Jun 30, 2025 39.26 Mn
Mar 31, 2025 50.79 Mn
Dec 31, 2024 60.42 Mn
Sep 30, 2024 30.72 Mn
Jun 30, 2024 38.90 Mn
Mar 31, 2024 45.52 Mn
Dec 31, 2023 31.22 Mn
Dec 31, 2022 52.60 Mn
Dec 31, 2021 80.62 Mn
Dec 31, 2020 97.35 Mn
Dec 31, 2019 14.14 Mn
Jan 1, 2019 19.52 Mn
Dec 31, 2018 20.17 Mn